Article Details
Retrieved on: 2024-04-04 19:19:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NEW YORK, April 4, 2024 /PRNewswire/ -- Aethon Therapeutics, Inc., a biotechnology ... immune system. This includes CD3+T cells and T ... cells, including ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here